338 related articles for article (PubMed ID: 9307345)
1. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.
Yonkers KA; Halbreich U; Freeman E; Brown C; Endicott J; Frank E; Parry B; Pearlstein T; Severino S; Stout A; Stone A; Harrison W
JAMA; 1997 Sep; 278(12):983-8. PubMed ID: 9307345
[TBL] [Abstract][Full Text] [Related]
2. Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.
Yonkers KA; Kornstein SG; Gueorguieva R; Merry B; Van Steenburgh K; Altemus M
JAMA Psychiatry; 2015 Oct; 72(10):1037-44. PubMed ID: 26351969
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.
Pearlstein TB; Halbreich U; Batzar ED; Brown CS; Endicott J; Frank E; Freeman EW; Harrison WM; Haskett RF; Stout AL; Yonkers KA
J Clin Psychiatry; 2000 Feb; 61(2):101-9. PubMed ID: 10732657
[TBL] [Abstract][Full Text] [Related]
4. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.
Halbreich U; Smoller JW
J Clin Psychiatry; 1997 Sep; 58(9):399-402. PubMed ID: 9378691
[TBL] [Abstract][Full Text] [Related]
5. Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.
Jermain DM; Preece CK; Sykes RL; Kuehl TJ; Sulak PJ
Arch Fam Med; 1999; 8(4):328-32. PubMed ID: 10418540
[TBL] [Abstract][Full Text] [Related]
6. Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.
Freeman EW; Rickels K; Sondheimer SJ; Polansky M; Xiao S
Am J Psychiatry; 2004 Feb; 161(2):343-51. PubMed ID: 14754784
[TBL] [Abstract][Full Text] [Related]
7. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial.
Young SA; Hurt PH; Benedek DM; Howard RS
J Clin Psychiatry; 1998 Feb; 59(2):76-80. PubMed ID: 9501889
[TBL] [Abstract][Full Text] [Related]
8. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.
Freeman EW; Rickels K; Sondheimer SJ; Polansky M
Arch Gen Psychiatry; 1999 Oct; 56(10):932-9. PubMed ID: 10530636
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.
Halbreich U; Bergeron R; Yonkers KA; Freeman E; Stout AL; Cohen L
Obstet Gynecol; 2002 Dec; 100(6):1219-29. PubMed ID: 12468166
[TBL] [Abstract][Full Text] [Related]
10. Does Symptom-Onset Treatment With Sertraline Improve Functional Impairment for Individuals With Premenstrual Dysphoric Disorder?: A Randomized Controlled Trial.
Yonkers KA; Altemus M; Gilstad-Hayden K; Kornstein SG; Gueorguieva R
J Clin Psychopharmacol; 2023 Jul-Aug 01; 43(4):320-325. PubMed ID: 37212651
[TBL] [Abstract][Full Text] [Related]
11. Sertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trial.
Freeman EW; Rickels K; Sondheimer SJ; Wittmaack FM
J Clin Psychiatry; 1996 Jan; 57(1):7-11. PubMed ID: 8543554
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, placebo-controlled pilot study of adjunctive quetiapine SR in the treatment of PMS/PMDD.
Jackson C; Pearson B; Girdler S; Johnson J; Hamer RM; Killenberg S; Meltzer-Brody S
Hum Psychopharmacol; 2015 Nov; 30(6):425-34. PubMed ID: 26193781
[TBL] [Abstract][Full Text] [Related]
13. Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies.
Kornstein SG; Pearlstein TB; Fayyad R; Farfel GM; Gillespie JA
J Clin Psychiatry; 2006 Oct; 67(10):1624-32. PubMed ID: 17107257
[TBL] [Abstract][Full Text] [Related]
14. [Psychiatric and psychological aspects of premenstrual syndrome].
Limosin F; Ades J
Encephale; 2001; 27(6):501-8. PubMed ID: 11865558
[TBL] [Abstract][Full Text] [Related]
15. Predictors of response to sertraline treatment of severe premenstrual syndromes.
Freeman EW; Sondheimer SJ; Polansky M; Garcia-Espagna B
J Clin Psychiatry; 2000 Aug; 61(8):579-84. PubMed ID: 10982201
[TBL] [Abstract][Full Text] [Related]
16. Treatment of premenstrual dysphoric disorder with the GABA
Bixo M; Ekberg K; Poromaa IS; Hirschberg AL; Jonasson AF; Andréen L; Timby E; Wulff M; Ehrenborg A; Bäckström T
Psychoneuroendocrinology; 2017 Jun; 80():46-55. PubMed ID: 28319848
[TBL] [Abstract][Full Text] [Related]
17. Sertraline in the treatment of premenstrual dysphoric disorder.
Yonkers KA; Halbreich U; Freeman E; Brown C; Pearlstein T
Psychopharmacol Bull; 1996; 32(1):41-6. PubMed ID: 8927673
[TBL] [Abstract][Full Text] [Related]
18. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries.
Cohen LS; Miner C; Brown EW; Freeman E; Halbreich U; Sundell K; McCray S
Obstet Gynecol; 2002 Sep; 100(3):435-44. PubMed ID: 12220761
[TBL] [Abstract][Full Text] [Related]
19. Sertraline for premenstrual dysphoric disorder.
Cohen LS
JAMA; 1998 Feb; 279(5):357-8. PubMed ID: 9459467
[No Abstract] [Full Text] [Related]
20. Is sertraline an effective therapy for premenstrual dysphoric disorder?
Fernandes O; Por CP; Evans MF
Can Fam Physician; 1998 Apr; 44():765-7. PubMed ID: 9585849
[No Abstract] [Full Text] [Related]
[Next] [New Search]
